PURPOSE: To identify risk factors associated with incomplete neurological recovery in pediatric patients with infratentorial ependymoma treated with postoperative conformal radiation therapy (CRT). METHODS: The study included 68 patients (median age +/- standard deviation of 2.6 +/- 3.8 years) who were followed for 5 years after receiving CRT (54-59.4 Gy) and were assessed for function of cranial nerves V to VII and IX to XII, motor weakness, and dysmetria. The mean (+/- standard deviation) brainstem dose was 5,487 (+/-464) cGy. Patients were divided into four groups representing those with normal baseline and follow-up, those with abnormal baseline and full recovery, those with abnormal baseline and partial or no recovery, and those with progressive deficits at 12 (n = 62 patients), 24 (n = 57 patients), and 60 (n = 50 patients) months. Grouping was correlated with clinical and treatment factors. RESULTS: Risk factors (overall risk [OR], p value) associated with incomplete recovery included gender (male vs. female, OR = 3.97, p = 0.036) and gross tumor volume (GTV) (OR/ml = 1.23, p = 0.005) at 12 months, the number of resections (>1 vs. 1; OR = 23.7, p = 0.003) and patient age (OR/year = 0.77, p = 0.029) at 24 months, and cerebrospinal fluid (CSF) shunting (Yes vs. No; OR = 21.9, p = 0.001) and GTV volume (OR/ml = 1.18, p = 0.008) at 60 months. An increase in GTV correlated with an increase in the number of resections (p = 0.001) and CSF shunting (p = 0.035); the number of resections correlated with CSF shunting (p < 0.0001), and male patients were more likely to undergo multiple tumor resections (p = 0.003). Age correlated with brainstem volume (p < 0.0001). There were no differences in outcome based on the absolute or relative volume of the brainstem that received more than 54 Gy. CONCLUSIONS: Incomplete recovery of brainstem function after CRT for infratentorial ependymoma is related to surgical morbidity and the volume and the extent of tumor. Copyright 2010 Elsevier Inc. All rights reserved.
PURPOSE: To identify risk factors associated with incomplete neurological recovery in pediatric patients with infratentorial ependymoma treated with postoperative conformal radiation therapy (CRT). METHODS: The study included 68 patients (median age +/- standard deviation of 2.6 +/- 3.8 years) who were followed for 5 years after receiving CRT (54-59.4 Gy) and were assessed for function of cranial nerves V to VII and IX to XII, motor weakness, and dysmetria. The mean (+/- standard deviation) brainstem dose was 5,487 (+/-464) cGy. Patients were divided into four groups representing those with normal baseline and follow-up, those with abnormal baseline and full recovery, those with abnormal baseline and partial or no recovery, and those with progressive deficits at 12 (n = 62 patients), 24 (n = 57 patients), and 60 (n = 50 patients) months. Grouping was correlated with clinical and treatment factors. RESULTS: Risk factors (overall risk [OR], p value) associated with incomplete recovery included gender (male vs. female, OR = 3.97, p = 0.036) and gross tumor volume (GTV) (OR/ml = 1.23, p = 0.005) at 12 months, the number of resections (>1 vs. 1; OR = 23.7, p = 0.003) and patient age (OR/year = 0.77, p = 0.029) at 24 months, and cerebrospinal fluid (CSF) shunting (Yes vs. No; OR = 21.9, p = 0.001) and GTV volume (OR/ml = 1.18, p = 0.008) at 60 months. An increase in GTV correlated with an increase in the number of resections (p = 0.001) and CSF shunting (p = 0.035); the number of resections correlated with CSF shunting (p < 0.0001), and male patients were more likely to undergo multiple tumor resections (p = 0.003). Age correlated with brainstem volume (p < 0.0001). There were no differences in outcome based on the absolute or relative volume of the brainstem that received more than 54 Gy. CONCLUSIONS: Incomplete recovery of brainstem function after CRT for infratentorial ependymoma is related to surgical morbidity and the volume and the extent of tumor. Copyright 2010 Elsevier Inc. All rights reserved.
Authors: Marie-Lise C van Veelen-Vincent; Alain Pierre-Kahn; Chantale Kalifa; Christian Sainte-Rose; Michel Zerah; John Thorne; Dominique Renier Journal: J Neurosurg Date: 2002-10 Impact factor: 5.115
Authors: Thomas E Merchant; Heather Lee; Junhong Zhu; Xiaoping Xiong; Gregory Wheeler; Sean Phipps; Frederick A Boop; Robert A Sanford Journal: J Neurosurg Date: 2004-11 Impact factor: 5.115
Authors: J Debus; E B Hug; N J Liebsch; D O'Farrel; D Finkelstein; J Efird; J E Munzenrider Journal: Int J Radiat Oncol Biol Phys Date: 1997-12-01 Impact factor: 7.038
Authors: A T Casey; E J Kimmings; A D Kleinlugtebeld; W A Taylor; W F Harkness; R D Hayward Journal: Pediatr Neurosurg Date: 1997-08 Impact factor: 1.162
Authors: Thomas E Merchant; Raymond K Mulhern; Matthew J Krasin; Larry E Kun; Tani Williams; Chenghong Li; Xiaoping Xiong; Raja B Khan; Robert H Lustig; Frederick A Boop; Robert A Sanford Journal: J Clin Oncol Date: 2004-08-01 Impact factor: 44.544
Authors: I F Pollack; P C Gerszten; A J Martinez; K H Lo; B Shultz; A L Albright; J Janosky; M Deutsch Journal: Neurosurgery Date: 1995-10 Impact factor: 4.654
Authors: Chiaho Hua; Thomas E Merchant; Amar Gajjar; Alberto Broniscer; Yong Zhang; Yimei Li; George R Glenn; Larry E Kun; Robert J Ogg Journal: Int J Radiat Oncol Biol Phys Date: 2011-06-12 Impact factor: 7.038
Authors: Erin S Murphy; Thomas E Merchant; Shengjie Wu; Xiaoping Xiong; Renin Lukose; Karen D Wright; Ibrahim Qaddoumi; Gregory T Armstrong; Alberto Broniscer; Amar Gajjar Journal: Int J Radiat Oncol Biol Phys Date: 2012-08-01 Impact factor: 7.038
Authors: Rituraj Upadhyay; Kaiping Liao; David R Grosshans; Susan L McGovern; Mary Frances McAleer; Wafik Zaky; Murali M Chintagumpala; Anita Mahajan; Debra Nana Yeboa; Arnold C Paulino Journal: Neuro Oncol Date: 2022-09-01 Impact factor: 13.029
Authors: Thomas Hundsberger; Michaela Tonder; Andreas Hottinger; Detlef Brügge; Ulrich Roelcke; Paul Martin Putora; Roger Stupp; Michael Weller Journal: J Neurooncol Date: 2014-04-16 Impact factor: 4.130